07:15 AM EDT, 04/20/2026 (MT Newswires) -- Episurf Medical (EPIS-B.ST) on Monday unveiled plans to carry out a dual-track process for the full separation of its medical technology operations as it initiates a strategic review of the business.

The review will focus on strategic alternatives, including the divestment of the medtech operations, its distribution to shareholders, and other measures.

The medical device company said the strategic review follows its assessment that its real estate and medtech units are "best positioned"for growth under separate structures.

Ämnen i artikeln

Episurf Medical B

Senast

0,06

1 dag %

−1,90%

1 dag

1 mån

1 år

Marknadsöversikt

1 DAG %

Senast

1 mån